These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prospects for personalized immunosuppression: pharmacologic tools--a review. Del Tacca M Transplant Proc; 2004 Apr; 36(3):687-9. PubMed ID: 15110631 [TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressive agents in organ transplantation]. Bergan S; Albrechtsen D; Bentdal O Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3615-20. PubMed ID: 10563181 [TBL] [Abstract][Full Text] [Related]
6. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppression in organ transplantation. Jordan SC; Rosenthal P; Makowka L Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042 [TBL] [Abstract][Full Text] [Related]
8. [Transplantation. Immunosuppression]. Häyry P; Gannedahl G Nord Med; 1994; 109(6-7):191-3. PubMed ID: 8015914 [TBL] [Abstract][Full Text] [Related]
10. Transplantation 1994: the year in review. Browne BJ; Kahan BD Clin Transpl; 1994; ():317-40. PubMed ID: 7547552 [TBL] [Abstract][Full Text] [Related]
11. Reviewing the evidence for de novo immunosuppression with sirolimus. Flechner SM Transplant Proc; 2008 Dec; 40(10 Suppl):S25-8. PubMed ID: 19100902 [TBL] [Abstract][Full Text] [Related]
12. Generic immunosuppression in solid organ transplantation: a Canadian perspective. Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158 [TBL] [Abstract][Full Text] [Related]
13. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. Valantine H J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppression in Solid-Organ Transplantation: Essentials and Practical Tips. Jasiak NM; Park JM Crit Care Nurs Q; 2016; 39(3):227-40. PubMed ID: 27254639 [TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor-free immunosuppression in kidney transplantation. Guerra G; Srinivas TR; Meier-Kriesche HU Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in solid organ transplantation: current status and future directions. de Jonge H; Kuypers DR Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854 [TBL] [Abstract][Full Text] [Related]
17. [Advances in immunossuppression in liver transplantation]. Olivera-Martínez MA Rev Invest Clin; 2005; 57(2):237-43. PubMed ID: 16524064 [TBL] [Abstract][Full Text] [Related]
18. The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments. Oellerich M; Armstrong VW Ther Drug Monit; 2006 Dec; 28(6):720-5. PubMed ID: 17164686 [No Abstract] [Full Text] [Related]